Dudediligence.

Adial Pharmaceuticals, Inc

ADILNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$2.2MSep ’24−$2.1MDec ’24−$2.2MMar ’25−$2.0MJun ’25−$1.8MSep ’25−$7.98TDec ’25−$2.0MMar ’26−$52.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$19.3M−$10.9M−$6.9M−$8.3M−$7.8M
Net income−$19.4M−$12.7M−$5.1M−$13.2M−$7.98T
Operating cash flow−$11.9M−$11.2M−$6.8M−$6.9M−$6.5M
Free cash flow−$12.0Mnone on filenone on filenone on filenone on file
Cash$6.1M$4.0M$2.8M$3.8M$5.9M
Shares outstanding20.9M1.1M1.7M258.8K1.1M